Aton Health

What Aton Health does

Aton Health is a privately held, Kansas City-based healthcare technology company founded around 2022 (per company history) that operates a non-interventional research platform embedding observational studies directly into routine specialty care workflows, initially focused on gastroenterology. The company builds and operates three integrated software products — TrialSight™ (embeds observational research into standard care and drives high-volume patient screening and enrollment), CareBeacon™ (longitudinal patient journey tracking and follow-up), and CareSight™ (infrastructure to activate evidence into standard of care, including dynamic risk stratification) — and pairs this technology with a clinician-led operating model that coordinates study execution on behalf of biotech sponsors inside large GI networks such as GI Alliance and Gastro Health.

Aton Health generates revenue primarily through enterprise B2B contracts with biotech and precision diagnostics sponsors that pay for non-interventional study execution, real-world evidence generation, and patient enrollment services delivered through the company's embedded provider network. The go-to-market is enterprise field sales, with the CEO and leadership team driving relationships directly with sponsor R&D and clinical development groups; pricing is quote-based and not publicly disclosed, consistent with project- and program-based recurring platform engagements. The customer base is bifurcated: on the supply side, specialty healthcare providers (gastroenterology practices) host the embedded research infrastructure; on the demand side, biotech sponsors — including Freenome and an unnamed precision diagnostics company referenced in case studies — purchase evidence-generation services. In June 2026, Aton Health closed a Series A growth investment led by Shore Search Partners (affiliated with Shore Capital Partners) to fund expansion beyond gastroenterology into additional medical specialties and healthcare markets.

Name

Aton Health

Legal name

Aton Holdings, Inc.

Website

https://atonhealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Aton Health is a Kansas City-based healthcare technology company that embeds non-interventional research directly into specialty care workflows, initially gastroenterology, providing biotech sponsors with real-world evidence generation, patient screening, and enrollment services through its TrialSight, CareBeacon, and CareSight platforms.

Ownership category

akta.pro rank

Product category

Real-World Evidence / Clinical Research Platform

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Real-World Evidence (RWE) & HEOR for Development (HLAIALAI)

akta.pro secondary industries

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

Keywords

• Non-interventional research
• Real-world evidence
• Clinical research platform
• Observational studies
• Health screening solutions

Headquarters

HQ city

Kansas City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Sponsor Research Platform Fees: Aton Health generates revenue by providing non-interventional research platform services to biotech and precision diagnostics sponsors. The company enables sponsor access to broader patient populations and real-world clinical evidence through its embedded provider network. Services include patient screening, enrollment, data collection, and study execution support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Aton Health embeds non-interventional (observational) research directly into routine specialty care to generate real-world clinical evidence for biotechnology and precision diagnostics sponsors. Its three integrated platforms—TrialSight™, CareBeacon™, and CareSight™—screen and enroll patients, track longitudinal journeys, and activate evidence into standards of care. The model is clinician-led and proven in gastroenterology, with the company expanding into additional medical specialties.

Product overview

Aton Health offers a multi-platform solution for non-interventional research embedded in routine patient care. The core portfolio consists of three integrated products: TrialSight™ for embedding observational research directly into standard care; CareBeacon™ for longitudinal patient journey tracking and insights; and CareSight™ for activating evidence into standard of care through infrastructure, people, and systems. The platform enables healthcare providers to participate in non-interventional research programs while supporting sponsors with access to broader patient populations and meaningful real-world clinical insights. The model is clinician-led, proven in gastroenterology, with expansion planned into additional medical specialties and healthcare markets.

Differentiator

Problem solved

Functional benefit

Brands

• TrialSight: Platform that embeds observational research directly into standard care, generating extraordinary evidence at unmatched speed.
• CareBeacon
• CareSight

Products and services

• TrialSight™ Platform that embeds observational research directly into standard specialty care, generating sponsor-grade real-world evidence at unmatched speed. Enables high-volume patient screening and enrollment into non-interventional studies for biotech and precision diagnostics sponsors and is the operational engine of Aton Health's research model.
• CareBeacon™ Platform that tracks, organizes, and monitors patient journeys from past to future, delivering longitudinal insights for ongoing care and research. Part of Aton Health's infrastructure for longitudinal data tracking and adoption.
• CareSight™ Platform that activates evidence into the standard of care through infrastructure, people, and systems, closing the loop from research to clinical adoption. Designed to help healthcare providers and sponsors implement clinical insights and accelerate the journey from innovation to standard of care.

Quantifiable outcome

• Tens of thousands of patients screened monthly across active research programs
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Three partnerships are on record, tiered core, flagship and minor.

• Gastro HealthcoreStrategic or Co-development Partner · 1 December 2025Gastro Health, a national gastroenterology platform (350+ physicians, 150+ locations across 7 states including Alabama, Florida, Maryland, Massachusetts, Ohio, Virginia, and Washington), partnered with Aton Health on an observational study pilot engaging 100+ clinicians and patients in colorectal cancer screening research to detect advanced adenomas and colorectal cancer in treatable stages. Dr. Chris Fourment, VP of Clinical Research at Gastro Health, leads the partnership.
• GI AllianceflagshipStrategic or Co-development Partner · 3 November 2025GI Alliance, the largest physician-led GI network in the U.S. (headquartered in Southlake, TX, supporting 950+ independent gastroenterologists in 345+ practice locations), extended its collaboration with Aton Health on new GI-focused clinical studies with 3 major biotech sponsors. The collaboration focuses on colorectal cancer screening and began as a pilot over three years ago. Dr. Casey Chapman, CMO of GI Alliance, serves as principal investigator.
• Fight Colorectal CancerminorStrategic or Co-development PartnerAton Health identifies Fight Colorectal Cancer as a potential key partner for patient communication and adherence in their proposed national framework for active surveillance and navigation after MCED detection. This is a prospective partnership mention rather than an established collaboration.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Flatiron Health: Roche-owned oncology RWE platform that aggregates de-identified patient data from specialty practices and serves biopharma sponsors — the closest comparable in terms of embedding RWE infrastructure into clinical workflows for sponsor evidence generation.
• Tempus: AI-driven precision medicine data platform providing real-world evidence, molecular profiling, and clinical trial enablement to biopharma — directly comparable on the biotech-sponsor RWE and precision diagnostics demand that Aton Health targets.
• ConcertAI: Specialty-focused RWE and AI analytics company serving oncology and other therapeutic sponsors with real-world data and evidence services — competes for the same embedded-specialty research budget as Aton Health.
• Medable: Decentralized clinical trial and eCOA platform enabling remote patient participation and provider-site enablement — comparable on the embedded/decentralized specialty research infrastructure model.
• Science 37: Decentralized clinical trial operator that brings research into community and specialty practices using a technology platform — closely aligned with Aton Health's "research embedded in routine care" thesis.
• COTA Healthcare: Oncology-focused real-world data and evidence company serving biopharma with curated longitudinal patient datasets — a comparable specialty-anchored RWE vendor competing for similar sponsor budgets.
• Syapse: Real-world evidence company partnering with community health systems and specialty providers to generate oncology data for biopharma — overlaps with Aton Health's provider-network embedding approach.
• Verana Health: Specialty EHR-integrated RWE platform (ophthalmology, neurology, oncology) selling curated real-world datasets to biopharma — directly comparable on embedding research infrastructure into specialty practice data.

Broad incumbents

• IQVIA: Global CRO and RWE incumbent with deep sponsor relationships across interventional and observational research — competes broadly for the same biotech and pharma RWE budgets that Aton Health targets.
• ICON plc: Large global CRO offering real-world evidence, late-phase, and decentralized trial services to biopharma — an incumbent alternative for sponsors considering Aton Health's embedded observational model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aton Health